Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.12M Buy
19,847
+1,978
+11% +$218K 0.03% 207
2026
Q1
$1.88M Buy
17,869
+371
+2% +$43.6K 0.03% 214
2025
Q4
$2.18M Buy
17,498
+73
+0.4% +$8.7K 0.03% 182
2025
Q3
$2.09M Sell
17,425
-151
-0.9% -$15.9K 0.03% 186
2025
Q2
$1.61M Sell
17,576
-1,019
-5% -$92.9K 0.02% 230
2025
Q1
$1.64M Buy
18,595
+471
+3% +$46.3K 0.03% 209
2024
Q4
$1.68M Buy
18,124
+170
+0.9% +$16.4K 0.03% 205
2024
Q3
$1.67M Sell
17,954
-2,206
-11% -$185K 0.03% 200
2024
Q2
$1.51M Sell
20,160
-6,161
-23% -$492K 0.03% 196
2024
Q1
$2.27M Buy
26,321
+626
+2% +$47.9K 0.04% 140
2023
Q4
$1.78M Buy
25,695
+6,210
+32% +$375K 0.04% 160
2023
Q3
$1.07M Buy
19,485
+40
+0.2% +$2.27K 0.03% 193
2023
Q2
$1.08M Buy
19,445
+7,937
+69% +$396K 0.02% 191
2023
Q1
$585K Sell
11,508
-717
-6% -$34K 0.01% 272
2022
Q4
$486K Buy
+12,225
New +$458K 0.01% 287

Other funds holding CRH

Ballentine Partners's CRH Position: Q2 2026 in Review

Ballentine Partners increased its CRH (CRH) stake by 11% in Q2 2026, buying an estimated $218K and bringing the position to 19,847 shares worth $2.12M. The position accounts for 0.03% of the portfolio, ranked #207.

Ballentine Partners first reported a position in CRH in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.27M in Q1 2024. 118 funds tracked by Wall St. Rank hold CRH as of Q2 2026.

  • Ballentine Partners held 19,847 shares of CRH worth $2.12M as of Q2 2026.
  • Ballentine Partners bought 1,978 CRH shares in Q2 2026, an estimated $218K.
  • CRH made up 0.03% of Ballentine Partners's portfolio in Q2 2026, its #207 holding.
  • Ballentine Partners first reported a position in CRH in Q4 2022 and has held it in 15 quarters since.
  • Ballentine Partners's CRH position peaked at $2.27M in Q1 2024.
  • 118 funds tracked by Wall St. Rank held CRH as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.